Abstract

Objective: It was aimed to retrospectively examine the clinical and survival results of patients who were consulted with the hematology clinic due to hematological disorders related to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Materials and methods: In this study, the data of patients who were hospitalized and consulted to the hematology clinic due to hematological disorders related to COVID-19 infection diagnosed by radiological findings and/or PCR results in the Ministry of Health Istanbul Training and Research Hospital between April 1 2020 and May 21 2020, were evaluated, retrospectively.
Results: Of the 48 patients evaluated in the study, 25 (52%) were female and 29 (60%) were 60 years old and above. Leukocytosis in 5(10%) patients, leukopenia in 19 (39%) patients, and D-Dimer ≥2ng/mL and Ferritin ≥500ml/ng in 32(66%) patients were remarkable. D-Dimer was found to be ≥2ng/mL and Ferritin ≥500ml/ng in 9 out of 10 patients in intensive care. A total of seven (14%) patients died. Conclusion: Patients who are over the age of 60, and have lymphocyte count <1000μl/ml, D-Dimer value above 2ng/mL, and ferritin over 500ml/ng are more likely to need a follow-up in the intensive care. For this reason, vaccination of people over the age of 60, moreover, the high antibody response obtained with the vaccine seems to be the most important precaution that can be taken against this disease.

Keywords:COVID-19; SARS-CoV-2; Gender; Hematology; Lymphopenia; Thrombocytopenia; Survival; Intensive care; D-dimer; Ferritin